Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 9
2006 16
2007 17
2008 24
2009 23
2010 29
2011 36
2012 32
2013 28
2014 32
2015 18
2016 4
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.
Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M; Prostate Cancer Clinical Trials Working Group. Scher HI, et al. J Clin Oncol. 2008 Mar 1;26(7):1148-59. doi: 10.1200/JCO.2007.12.4487. J Clin Oncol. 2008. PMID: 18309951 Free PMC article.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
Against diagnosis.
Vickers AJ, Basch E, Kattan MW. Vickers AJ, et al. Ann Intern Med. 2008 Aug 5;149(3):200-3. doi: 10.7326/0003-4819-149-3-200808050-00010. Ann Intern Med. 2008. PMID: 18678847 Free PMC article.
Validation and clinical utility of prostate cancer biomarkers.
Scher HI, Morris MJ, Larson S, Heller G. Scher HI, et al. Nat Rev Clin Oncol. 2013 Apr;10(4):225-34. doi: 10.1038/nrclinonc.2013.30. Epub 2013 Mar 5. Nat Rev Clin Oncol. 2013. PMID: 23459624 Free PMC article. Review.
How to randomize.
Vickers AJ. Vickers AJ. J Soc Integr Oncol. 2006 Fall;4(4):194-8. doi: 10.2310/7200.2006.023. J Soc Integr Oncol. 2006. PMID: 17022927 Free PMC article. Review.
Circulating tumor cells as biomarkers in prostate cancer.
Danila DC, Fleisher M, Scher HI. Danila DC, et al. Clin Cancer Res. 2011 Jun 15;17(12):3903-12. doi: 10.1158/1078-0432.CCR-10-2650. Clin Cancer Res. 2011. PMID: 21680546 Free PMC article. Review.
High-field small animal magnetic resonance oncology studies.
Bokacheva L, Ackerstaff E, LeKaye HC, Zakian K, Koutcher JA. Bokacheva L, et al. Phys Med Biol. 2014 Jan 20;59(2):R65-R127. doi: 10.1088/0031-9155/59/2/R65. Epub 2013 Dec 30. Phys Med Biol. 2014. PMID: 24374985 Free PMC article. Review.
229 results